These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8380129)

  • 81. p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
    Ozturk M
    Lancet; 1991 Nov; 338(8779):1356-9. PubMed ID: 1682737
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
    Ghebranious N; Knoll BJ; Wu H; Lozano G; Sell S
    Mol Carcinog; 1995 Jun; 13(2):104-11. PubMed ID: 7605578
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro aflatoxin B1-induced p53 mutations.
    Chan KT; Hsieh DP; Lung ML
    Cancer Lett; 2003 Sep; 199(1):1-7. PubMed ID: 12963117
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.
    Woo LL; Egner PA; Belanger CL; Wattanawaraporn R; Trudel LJ; Croy RG; Groopman JD; Essigmann JM; Wogan GN; Bouhenguel JT
    Toxicol Sci; 2011 Jul; 122(1):38-44. PubMed ID: 21507988
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
    Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes.
    Masui T; Nakanishi H; Inada K; Imai T; Mizoguchi Y; Yada H; Futakuchi M; Shirai T; Tatematsu M
    Cancer Lett; 1997 Jan; 112(1):33-45. PubMed ID: 9029167
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Aflatoxin B1 and/or hepatitis B virus induced tumor spectrum in a genetically engineered hepatitis B virus expression and Trp53 haploinsufficient mouse model system for hepatocarcinogenesis.
    Cullen JM; Brown DL; Kissling GE; Foley JF; Rizzo J; Marion PL; Parron VI; French JE
    Toxicol Pathol; 2009 Apr; 37(3):333-42. PubMed ID: 19258306
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1.
    Yang L; Ji J; Chen Z; Wang H; Li J
    Neoplasma; 2014; 61(2):193-204. PubMed ID: 24299315
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene.
    Hussain SP; Aguilar F; Amstad P; Cerutti P
    Oncogene; 1994 Aug; 9(8):2277-81. PubMed ID: 8036011
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
    McMahon G; Davis EF; Huber LJ; Kim Y; Wogan GN
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1104-8. PubMed ID: 2105496
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Urata K; Tanaka S; Sugimachi K
    Liver; 1993 Oct; 13(5):279-81. PubMed ID: 8259041
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
    Groopman JD; Roebuck BD; Kensler TW
    Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Isolation of a metastasizing cancer cell line from an aflatoxin B1-induced rat liver tumor.
    Akao M; Kuroda K; Gonoi T; Kishikawa S
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1299-302. PubMed ID: 1327557
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Genome-wide miRNA-profiling of aflatoxin B1-induced hepatic injury using deep sequencing.
    Yang W; Lian J; Feng Y; Srinivas S; Guo Z; Zhong H; Zhuang Z; Wang S
    Toxicol Lett; 2014 Apr; 226(2):140-9. PubMed ID: 24472605
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.
    Dong-Dong L; Xi-Ran Z
    J Cell Mol Med; 2003; 7(1):89-92. PubMed ID: 12767266
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
    Liu SP; Li YS; Lee CM; Yen CH; Liao YJ; Huang SF; Chien CH; Chen YM
    Int J Cancer; 2011 Feb; 128(3):511-23. PubMed ID: 20473876
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low Frequency of Aflatoxin Induced TP53 Gene Codon 249 Mutation in Hepatocellular Carcinoma from Egyptian Patients Living in the Nile Delta Region.
    Mosbeh A; Abdelmaguid W; Ezzat S; Kohla M; Sultan MM; Abdel-Rahman MH
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3165-3168. PubMed ID: 37774068
    [TBL] [Abstract][Full Text] [Related]  

  • 98. New species of messenger RNA in aflatoxin B1 induced hepatocellular carcinoma.
    Pironcheva GL; Russev GH
    Cytobios; 1986; 46(185):73-8. PubMed ID: 3089699
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Changes of beta catenin in carcinogenesis in rat livers induced by aflatoxin B1].
    Jiao Y; Ban KC; Cao J; Yue HY; Chen MW; Su JJ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):783-4. PubMed ID: 17963611
    [No Abstract]   [Full Text] [Related]  

  • 100. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins.
    Gerbes AL; Caselmann WH
    J Hepatol; 1993 Sep; 19(2):312-5. PubMed ID: 8301066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.